Skip to main content
Log in

Hyperhomocysteinemia as a Risk Factor for IUGR

  • Original Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Objective

To study the role of hyperhomocysteinemia in patients with intrauterine growth retardation.

Method

76 patients with intrauterine growth retardation were studied and compared with 50 controls which included pregnant patients without any pregnancy complications. Fasting Plasma homocysteine levels were measured and statistical analysis using tests of significance and logistic regression analysis was performed. Those in the study group were given homocysteine lowering agents for 6 wks and pregnancy outcome was studied.

Results

57.8 % women in the study group were found to have hyperhomocysteinemia. Logistic Regression analysis shows an OR of 2.45 in favor of occurrence of IUGR if homocysteine levels are raised which is statistically significant. Mean plasma homocysteine levels decreased after treatment for 6 wks but this decrease in the case of placebo group is marginal whereas the decrease in the homocysteine levels the treatment group. This implies that treatment has a definitive role in lowering of plasma homocysteine levels.

Conclusion

The present study shows that hyperhomocysteinemia is associated with IUGR and should be identified as a risk factor as correction favors pregnancy outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Martinelli P, Grandone E, Colaizzo D, et al. Familial thrombophilia and the occurrence of fetal growth restriction. Haematologica. 2001;86:428–31.

    PubMed  CAS  Google Scholar 

  2. Arias F, Romero R, Joist H, et al. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta. J Matern Fetal Med. 1998;7:277–86.

    Article  PubMed  CAS  Google Scholar 

  3. Many A, Screiber L, Rosner S, et al. Pathologic features of placenta in women with severe pregnancy complications and thrombophilia. Obstet Gynecol. 2001;98:1041–4.

    Article  PubMed  CAS  Google Scholar 

  4. Steegers-Theunissen RP, Van Iersel CA, Peer PG, et al. Hyperhomocysteinemia, pregnancy complications, and the timing of investigation. Obstet Gynecol. 2004;104:336–43.

    Article  PubMed  CAS  Google Scholar 

  5. Lindblad B, Zaman S, Malik A, et al. Vitamin B12, and homocysteine levels in South Asian Women with growth-retarded fetuses. Obstet Gynecol Surv. 2006;61:91–2.

    Article  Google Scholar 

  6. Leeda M, Riyazi N, de vries JIP, et al. Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of growth restriction or preeclampsia. Am J Obstet Gynecol. 1998;179:135–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kiran Pandey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pandey, K., Dubay, P., Bhagoliwal, A. et al. Hyperhomocysteinemia as a Risk Factor for IUGR. J Obstet Gynecol India 62, 406–408 (2012). https://doi.org/10.1007/s13224-012-0287-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-012-0287-9

Keywords

Navigation